Viewing Study NCT02385669


Ignite Creation Date: 2025-12-24 @ 10:49 PM
Ignite Modification Date: 2026-02-20 @ 4:46 PM
Study NCT ID: NCT02385669
Status: TERMINATED
Last Update Posted: 2020-05-05
First Post: 2015-03-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma
Sponsor: Craig L Slingluff, Jr
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None vaccine View
None peptide View
None ipilimumab View
None Yervoy View
None Montanide ISA-51 View